IOBT
IO Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · DK
$0.01
−27.59%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +1.0%
- EBIT
- +4.5%
- EPS
- +1.5%
- Free cash flow
- +5.4%
- Operating cash flow
- +5.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- -10.3%
- EBIT
- -4.1%
- Net income
- -10.9%
- EPS
- +26.8%
- Free cash flow
- -14.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2025